Andere talen HTG Molecular Diagnostics, Inc.

Aandelen

HTGMQ

US40434H3021

Beurs gesloten - OTC Markets Andere beurzen 21:55:07 10-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,0025 ^USD	0,00%		0,00%	+92,31%

2023	Curator/examinator aangesteld onder Chapter 11 voor HTG Molecular Diagnostics, Inc.	CI
2023	Htg Molecular Diagnostics, Inc. kondigt de beëindiging aan van het dienstverband van Byron T. Lawson als Senior Vice President en Chief Commercial Officer	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Motion for De Minimus Asset Sale Approved for HTG Molecular Diagnostics, Inc.	25-08-23
Motion for De Minimus Asset Sale Filed by HTG Molecular Diagnostics, Inc.	16-08-23
Trustee/Examiner Appointed Under Chapter 11 for HTG Molecular Diagnostics, Inc.	21-07-23
HTG Molecular Diagnostics, Inc.(OTCPK:HTGM.Q) dropped from NASDAQ Composite Index	14-06-23
HTG MOLECULAR DIAGNOSTICS, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	08-06-23
HTG Molecular Diagnostics, Inc.(NasdaqCM:HTGM) dropped from S&P TMI Index	08-06-23
Htg Molecular Diagnostics, Inc. Announces Termination of Employment of Byron T. Lawson as Senior Vice President and Chief Commercial Officer	05-06-23
HTG Molecular Diagnostics, Inc. Filed for Bankruptcy	05-06-23
HTG to Highlight the Advantages of its Drug Discovery Engine at the 2023 BIO International Convention	18-05-23
HTG Molecular Diagnostics, Inc. to Highlight the Advantages of its Drug Discovery Engine at the 2023 Biotechnology Innovation Organization	18-05-23
Top Premarket Gainers	17-05-23
HTG Highlights the Advantages of Its Drug Discovery Engine	16-05-23
HTG Molecular Diagnostics : Reports First Quarter 2023 Results and Provides Recent Business Highlights - Form 8-K	11-05-23
HTG Molecular Diagnostics Reports First Quarter 2023 Results and Provides Recent Business Highlights	10-05-23
HTG MOLECULAR DIAGNOSTICS, INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	10-05-23
HTG Molecular Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	10-05-23
HTG MOLECULAR DIAGNOSTICS, INC : Other Events (form 8-K)	25-04-23
HTG Provides Update on Drug Discovery Partnering Initiative	25-04-23
HTG Announces Key First Quarter Milestone Achievements for Drug Discovery	18-04-23
HTG Technology Featured in Numerous Scientific Posters at the AACR Annual Meeting April 16-19	06-04-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen HTG Molecular Diagnostics, Inc.

Aandelen

HTGMQ

US40434H3021

Andere talen

Filters